High-Affinity Sigma-1 (σ₁) Receptor Ligands Based on the σ₁ Antagonist PB212

References

• Hanner M , MoebusFF, FlandorferAet al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl Acad. Sci. USA93, 8072–8077 (1996).
   PubMed Web of Science ®Google Scholar
• Schmidt HR , ZhengS, GurpinarE, KoehlA, ManglikA, KruseAC. Crystal structure of the human σ1 receptor. Nature532, 527–530 (2016).
   PubMed Web of Science ®Google Scholar
• Schmidt HR , BetzR, DrorRO, KruseAC. Structural basis for σ1 receptor ligand recognition. Nat. Struct. Mol. Biol.25, 981–987 (2018).
   PubMed Web of Science ®Google Scholar
• Alon A , SchmidtHR, WoodMD, SahnJJ, MartinSF, KruseAC. Identification of the gene that codes for the σ2 receptor. Proc. Natl Acad. Sci. USA114, 7160–7165 (2017).
   PubMed Web of Science ®Google Scholar
• Abate C , NisoM, InfantinoV, MengaA, BerardiF. Elements in support of the ‘non-identity’ of the PGRMC1 protein with the σ2 receptor. Eur. J. Pharmacol.758, 16–23 (2015).
   PubMed Web of Science ®Google Scholar
• Chu UB , MavlyutovT, ChuMLet al. The sigma-2 receptor and progesterone receptor membrane component 1 are different binding sites derived from independent genes. EBioMedicine2, 1806–1813 (2015).
   PubMed Web of Science ®Google Scholar
• Pati ML , GrozaD, RigantiCet al. Sigma-2 receptor and progesterone receptor membrane component 1 (PGRMC1) are two different proteins: proofs by fluorescent labeling and binding of sigma-2 receptor ligands to PGRMC1. Pharmacol. Rep.117, 67–74 (2017).
   Google Scholar
• Su TP , SuTC, NakamuraY, TsaiSY. The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol. Sci.37, 262–278 (2016).
   PubMed Web of Science ®Google Scholar
• Rennekamp AJ , HuangXP, WangYet al. σ1 Receptor ligands control a switch between passive and active threat responses. Nat. Chem. Biol.12, 552–558 (2016).
   PubMed Web of Science ®Google Scholar
• Smith SB , SuTP. Sigma Receptors: Their Role in Disease and as Therapeutic Targets, Volume 964. Springer International Publishing AG, Cham, Switzerland (2017).
   Google Scholar
• Berardi F , FerorelliS, AbateCet al. Methyl substitution on the piperidine ring of N-[ω-(6-Methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the σ1 receptor. J. Med. Chem.48, 8237–8244 (2005).
   PubMed Web of Science ®Google Scholar
• Skuza G , SadajW, KabińskiMet al. The effects of new sigma (σ) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity. Pharmacol. Rep.66, 320–324 (2014).
   PubMed Web of Science ®Google Scholar
• Gasparre G , AbateC, BerardiF, CassanoG. The sigma-1 receptor antagonist PB212 reduces the Ca2+-release through the inositol (1, 4, 5)-trisphosphate receptor in SK-N-SH cells. Eur. J. Pharmacol.684, 59–63 (2012).
   PubMed Web of Science ®Google Scholar
• Skuza G , SzymańskaM, BudziszewskaB, AbateC, BerardiF. Effects of PB190 and PB212, new σ receptor ligands, on glucocorticoid receptor-mediated gene transcription in LMCAT cells. Pharmacol. Rep.63, 1564–1568 (2011).
   PubMed Web of Science ®Google Scholar
• Niso M , AbateC, FerorelliSet al. Investigation of σ receptors agonist/antagonist activity through N-(6-methoxytetralin-1-yl)- and N-(6-methoxynaphthalen-1-yl)alkyl derivatives of Polymethylpiperidines. Bioorg. Med. Chem.21, 1865–1869 (2013).
   PubMed Web of Science ®Google Scholar
• Glennon RA . Pharmacophore identification for sigma-1 (σ1) receptor binding: application of the “deconstruction–reconstruction–elaboration” approach. Mini-Rev. Med. Chem.5, 927–940 (2005).
   PubMed Web of Science ®Google Scholar
• Matsumoto RR , BowenWD, TomMA, TruongDD, DeCosta BR. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur. J. Pharmacol.280, 301–310 (1995).
   PubMed Web of Science ®Google Scholar
• Niso M , RigantiC, PatiML, GhigoD, BerardiF, AbateC. Novel and selective fluorescent σ2 -receptor ligand with a 3,4-dihydroisoquinolin-1-one scaffold: a tool to study σ2 receptors in living Cells. Chembiochem.16, 1078–1083 (2015).
   PubMed Web of Science ®Google Scholar
• Galiano M , GasparreG, LippeC, CassanoG. Calcium response after stimulation by substance P of U373 MG cells: inhibition of store-operated calcium entry by protein kinase C. Cell Calcium35, 123–130 (2004).
   PubMed Web of Science ®Google Scholar
• Gasparre G , AbateC, CarlucciR, BerardiF, CassanoG. The σ1 receptor agonist (+)-pentazocine increases store-operated Ca2+ Entry in MCF7σ1 and SK-N-SH cell lines. Pharmacol. Rep.69, 542–545 (2017).
   PubMed Web of Science ®Google Scholar
• Eswar N , WebbB, Marti-RenomMAet al. Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. (Suppl. 50), 2.9.1–2.9.31 (2007).
   PubMedGoogle Scholar
• Jones G , WillettP, GlenRC, LeachAR, TaylorR. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol.267, 727–748 (1997).
   PubMed Web of Science ®Google Scholar
• Alix K , KhatriS, MosierPDet al. Superagonist, full agonist, partial agonist, and antagonist actions of arylguanidines at 5-hydroxytryptamine-3 (h5-HT3) Subunit A Receptors. ACS Chem. Neurosci.7, 1565–1574 (2016).
   PubMed Web of Science ®Google Scholar
• Barré B , GonnardL, CampagneRet al. Iron- and cobalt-catalyzed arylation of azetidines, pyrrolidines, and piperidines with grignard reagents. Org. Lett.16, 6160–6163 (2014).
   PubMed Web of Science ®Google Scholar
• Macchia M , CervettoL, DemontisGCet al. New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor. J. Med. Chem.46, 161–168 (2003).
   PubMed Web of Science ®Google Scholar
• Lindsay Smith JR , NormanROC, RowleyAG. Amine oxidation. Part VI. Metal-ion induced dehydrative cyclisation, reduction, and reductive fragmentation of arylethyldimethylamine N-oxides. J. Chem. Soc. Perkin Trans.1, 228–234 (1972).
   Google Scholar
• Sari O , BoucleS, CoxBDet al. Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector. Eur. J. Med. Chem.138, 407–421 (2017).
   PubMed Web of Science ®Google Scholar
• Audouze K , NielsenEØ, OlsenGMet al. New ligands with affinity for the α4β2 subtype of nicotinic acetylcholine receptors. synthesis, receptor binding, and 3D-QSAR modeling. J. Med. Chem.49, 3159–3171 (2006).
   PubMedGoogle Scholar
• Abate C , PatiML, ContinoMet al. From mixed sigma-2 receptor/p-glycoprotein targeting agents to selective p-glycoprotein modulators: small structural changes address the mechanism of interaction at the efflux pump. Eur. J. Med. Chem.89, 606–615 (2015).
   PubMed Web of Science ®Google Scholar
• Abate C , SelivanovaSV, MüllerAet al. Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the positron emission tomography (PET) imaging of σ2 receptors. Eur. J. Med. Chem.69, 920–930 (2013).
   PubMed Web of Science ®Google Scholar
• Niso M , AbateC, ContinoM, FerorelliSet al. Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity. ChemMedChem8, 2026–2035 (2013).
   PubMed Web of Science ®Google Scholar
• Niso M , PatiML, BerardiF, AbateC. Rigid versus flexible anilines or anilides confirm the bicyclic ring as the hydrophobic portion for optimal σ2 receptor binding and provide novel tools for the development of future σ2 receptor PET radiotracers. RSC Adv.6, 88508–88518 (2016).
   Web of Science ®Google Scholar
• Wu Z , BowenWD. Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells. J. Biol. Chem.283, 28198–28215 (2008).
   PubMed Web of Science ®Google Scholar
• Vilner BJ , BowenWD. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. J. Pharmacol. Exp. Ther.292, 900–911 (2000).
   PubMed Web of Science ®Google Scholar
• Abate C , NisoM, LacivitaE, MosierPD, ToscanoA, PerroneR. Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers. J. Med. Chem.54, 1022–1032 (2011).
   PubMed Web of Science ®Google Scholar
• Kim FJ , PasternakGW. σ1 receptor ligand binding: an an open-and-shut case. Nat. Struct. Mol. Biol.25, 992–993 (2018).
   PubMed Web of Science ®Google Scholar
• Sguazzini E , SchmidtHR, IyerKA, KruseAC, DukatM. Reevaluation of fenpropimorph as a σ receptor ligand: structure–affinity relationship studies at human σ1 receptors. Bioorg. Med. Chem. Lett.27, 2912–2919 (2017).
   PubMed Web of Science ®Google Scholar
• Singh SK , DasA. The n→π* interaction: a rapidly emerging non-covalent interaction. Phys. Chem. Chem. Phys.17, 9596–9612 (2015).
   PubMed Web of Science ®Google Scholar
• Gris G , Portillo-SalidoE, AubelB, DarbakyYet al. The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats. Sci. Rep.6, 24591 (2016).
   PubMed Web of Science ®Google Scholar
• Clinical trials database . NCT02753101. https://clinicaltrials.gov/ct2/show/NCT02753101
   Google Scholar
• Clinical trials database . NCT03790709. https://clinicaltrials.gov/ct2/show/NCT03790709
   Google Scholar
• Clinical trials database . NCT03019289. https://clinicaltrials.gov/ct2/show/NCT03019289
   Google Scholar